argenx SE
ARGX
925.70
-16.34
-1.73%
argenx SE
US · ARGX
#369 by market cap
Listed 2017
925.70
-16.34
-1.73%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Official SEC filings
Source: SEC EDGAR. Latest available cached filings; filing date is not the financial period end. Index checked: 2026-11-22 03:43 UTC.
| Form | Filed | Original document |
|---|---|---|
| 6-K | 2026-11-09 | Read on SEC.gov |
| 6-K | 2026-11-09 | Read on SEC.gov |
| 6-K | 2026-10-22 | Read on SEC.gov |
| 6-K | 2026-10-19 | Read on SEC.gov |
| 6-K | 2026-10-08 | Read on SEC.gov |
| 6-K | 2026-09-29 | Read on SEC.gov |
| 6-K | 2026-08-27 | Read on SEC.gov |
| 6-K | 2026-08-17 | Read on SEC.gov |
Revenue annual, last 8 years
Margins
- Gross margin
- 89.15%
- Operating margin
- 25.39%
- Net margin
- 31.11%
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 24.57M | 78.46M | -- | -- | -- | -- | -- | -- |
| Gross profit | -- | -- | 41.24M | 497.28M | 381.32M | 1.11B | 1.96B | 3.70B |
| Selling & admin expenses | 31.42M | 72.15M | 170.55M | 305.52M | 469.92M | 709.54M | 1.05B | 1.36B |
| Research & development | 95.64M | 220.77M | 370.89M | 580.52M | 663.37M | 859.49M | 983.42M | 1.36B |
| Operating profit | -93.63M | -200.11M | -480.57M | -359.90M | -723.92M | -420.64M | -17.84M | 1.05B |
| Pretax profit | -75.32M | -175.92M | -605.35M | -399.74M | -729.31M | -304.50M | 85.18M | 1.28B |
| Tax | 908.26K | 5.29M | 3.10M | 8.52M | -19.72M | -9.44M | -747.86M | -13.43M |
| Net profit | -76.23M | -181.21M | -608.46M | -408.27M | -709.59M | -295.05M | 833.04M | 1.29B |
| Basic EPS | -2 | -5 | -13 | -8 | -13 | -5 | 14 | 21 |
| Diluted EPS | -2.28 | -4.69 | -13.40 | -7.99 | -13.05 | -5.16 | 12.78 | 19.57 |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Revenue | 949.00M | 1.13B | -- | 1.30B | 1.52B | 1.72B |
| Gross profit | 838.00M | 1.02B | 1.14B | 1.18B | 1.37B | 1.56B |
| Selling & admin expenses | 321.00M | 336.00M | 422.98M | 355.00M | 411.00M | 598.00M |
| Research & development | 331.00M | 359.00M | 363.13M | 443.00M | 486.00M | 503.00M |
| Operating profit | 201.00M | 347.00M | 367.62M | 394.00M | 494.00M | 485.00M |
| Pretax profit | 287.00M | 386.00M | 403.61M | 426.00M | 532.00M | 538.00M |
| Tax | 41.00M | 42.00M | -129.43M | 60.00M | 59.00M | 32.00M |
| Net profit | 246.00M | 344.00M | 533.04M | 366.00M | 472.00M | 506.00M |
| Basic EPS | 4 | 6 | 9 | 6 | 8 | 8 |
| Diluted EPS | 3.74 | 5.18 | 8.06 | 5.52 | 7.48 | 7.80 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 654.82M | 1.54B | 2.06B | 2.54B | 2.77B | 4.12B | 4.88B | 6.90B |
| Cash & ST investments | 645.81M | 1.50B | 2.00B | 2.34B | 2.19B | 3.18B | 3.38B | 4.44B |
| Inventory | 0 | 0 | 25.20M | 109.08M | 228.35M | 310.55M | 407.23M | 473.53M |
| Total assets | 661.70M | 1.61B | 2.28B | 2.85B | 3.13B | 4.54B | 6.20B | 8.68B |
| Total current liabilities | 45.82M | 179.70M | 328.49M | 301.24M | 302.28M | 422.99M | 669.92M | 1.32B |
| Short-term debt | -- | 2.22M | 3.48M | 3.51M | 3.42M | 4.65M | 6.53M | 10.83M |
| Long-term debt | -- | -- | -- | -- | -- | -- | -- | -- |
| Total liabilities | 45,828,185.77 | 429,806,000.00 | 605,356,000.00 | 316,050,000.00 | 320,562,000.00 | 444,951,000.00 | 704,239,000.00 | 1,359,606,000.00 |
| Total equity | 615.87M | 1.18B | 1.67B | 2.53B | 2.81B | 4.10B | 5.50B | 7.32B |
| Retained earnings | -194.01M | -383.48M | -991.93M | -1.40B | -2.11B | -2.40B | -1.57B | -279.77M |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Total current assets | 5.83B | -- | 6.90B | -- | 8.07B | -- |
| Cash & ST investments | 3.93B | -- | 4.44B | -- | 5.18B | -- |
| Inventory | 340.62M | -- | 473.53M | -- | 371.00M | -- |
| Total assets | 7.18B | -- | 8.68B | -- | 10.03B | -- |
| Total current liabilities | 1.04B | -- | 1.32B | -- | 1.58B | -- |
| Short-term debt | 7.58M | -- | 10.83M | -- | 11.00M | -- |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 1,079,840,000.00 | -- | 1,359,606,000.00 | -- | 1,615,000,000.00 | -- |
| Total equity | 6.10B | -- | 7.32B | -- | 8.42B | -- |
| Retained earnings | -1.16B | -- | -279.77M | -- | 558.00M | -- |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -61.59M | 151.63M | -398.46M | -606.81M | -862.81M | -420.33M | -82.75M | 685.19M |
| Depreciation & amortization | 563.94K | 2.43M | 3.92M | 5.87M | 104.34M | 111.31M | 17.53M | 28.10M |
| Free cash flow | -62.37M | 104.90M | -403.60M | -728.25M | -966.63M | -464.14M | -151.05M | 573.51M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 292.52M | 755.64M | 813.19M | 1.09B | 760.95M | 1.20B | 0 | 0 |
| Ending cash balance | 321.48M | 372.16M | 1.22B | 1.33B | 800.74M | 2.05B | 1.50B | 3.49B |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Operating cash flow | -- | -- | -- | -- | -- | -- |
| Depreciation & amortization | -- | -- | -- | -- | -- | -- |
| Free cash flow | -- | -- | -- | -- | -- | -- |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | -- | -- | -- | -- | -- | -- |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -14.81 | -20.36 | -45.57 | -19.38 | -26.54 | -8.54 | 17.36 | 20.15 |
| ROA %i | -13.78 | -16.10 | -33.44 | -15.90 | -23.71 | -7.69 | 15.51 | 17.36 |
| ROIC %i | -15.03 | -20.90 | -45.21 | -19.37 | -27.24 | -11.07 | 15.16 | 18.19 |
| 5-year avg ROE %i | -26.24 | -24.76 | -26.70 | -22.21 | -24.71 | -23.46 | -15.95 | -3.39 |
| EBIT margin %i | -381.01 | -226.54 | -1,440.56 | -80.17 | -177.02 | -24.76 | 4.00 | 30.88 |
| FCF / sales %i | -- | 133.04 | -- | -- | -- | -- | -- | 13.81 |
| Current ratioi | 14.29 | 8.58 | 6.26 | 8.44 | 9.18 | 9.75 | 7.29 | 5.23 |
| Quick ratioi | 14.17 | 8.53 | 6.10 | 7.88 | 8.17 | 8.70 | 6.40 | 4.62 |
| Debt / assetsi | 0.00 | 0.45 | 0.42 | 0.40 | 0.40 | 0.44 | 0.63 | 0.54 |
| LT debt / equityi | -- | 0.43 | 0.37 | 0.31 | 0.32 | 0.37 | 0.59 | 0.50 |
| Interest coveragei | -- | -1,274.91 | -371.09 | -363.73 | -331.56 | -335.83 | 35.57 | 314.23 |
| Revenue CAGR (3Y) %i | 48.57 | 71.80 | -1.90 | 172.51 | 73.64 | 209.80 | 63.92 | 116.25 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | 117.17 | -- | -- | -- | -- | -- | -- |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| ROE %i | 24.72 | -- | 20.15 | -- | 23.63 | -- |
| ROA %i | 21.39 | -- | 17.36 | -- | 19.93 | -- |
| ROIC %i | 22.65 | -- | 18.19 | -- | 21.14 | -- |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 21.86 | 26.78 | 30.88 | 32.32 | 33.51 | 32.68 |
| FCF / sales %i | 10.11 | -- | 13.81 | -- | 17.28 | -- |
| Current ratioi | 5.60 | -- | 5.23 | -- | 5.12 | -- |
| Quick ratioi | 4.92 | -- | 4.62 | -- | 4.52 | -- |
| Debt / assetsi | 0.60 | -- | 0.54 | -- | 0.47 | -- |
| LT debt / equityi | 0.58 | -- | 0.50 | -- | 0.43 | -- |
| Interest coveragei | 183.31 | 244.01 | 314.23 | 369.11 | 429.13 | 466.12 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Product net sales100.00%
Region
United States85.13%
Rest of the World8.25%
Japan4.98%
China1.64%
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
argenx SE discussion 0 comments